Vedana Therapeutics raised $46 million in Series A funding. The financing will support the company's development of small molecule therapies targeting neurodegenerative diseases. The round was led by a syndicate of healthcare investors.
Tap to vote and see what everyone thinks.
Summary by ByteBrief